Sort By

ERK1/ERK2 Recombinant Polyclonal Antibody (3HCLC) (Invitrogen™)

ERK1/ERK2 Recombinant Polyclonal Antibody for Western Blot, ChIP

LanthaScreen™ Tb-anti-ERK2 [pThr185/pTyr187] Antibody

A part of the MAPK Pathway, ERK2 is phosphorylated at Thr185 and Tyr187 by the mitogen-activated protein kinase kinases 2 (MAP2K2) .
For use in combination with the LanthaScreen® ERK2 A375 cell line (K1798) to evaluate inhibitors in medium to high throughput screening applications.

ERK1/ERK2 Recombinant Polyclonal Antibody (6HCLC) (Invitrogen™)

ERK1/ERK2 Recombinant Polyclonal Antibody for Western Blot, ChIP

ERK2 Polyclonal Antibody (Invitrogen™)

ERK2 Polyclonal Antibody for Western Blot, IHC (P), IP

ERK2 Polyclonal Antibody (Invitrogen™)

ERK2 Polyclonal Antibody for Western Blot, IHC

ERK2 Polyclonal Antibody (Invitrogen™)

ERK2 Polyclonal Antibody for Western Blot, pep-ELISA

ERK2 Polyclonal Antibody (Invitrogen™)

ERK2 Polyclonal Antibody for Western Blot, IHC (P), Flow

ERK2 Monoclonal Antibody (1A1) (Invitrogen™)

ERK2 Monoclonal Antibody for Western Blot, IP

ERK2 Polyclonal Antibody (Invitrogen™)

ERK2 Polyclonal Antibody for Western Blot, IHC (P), IP, ChIP

ERK2 Polyclonal Antibody (Invitrogen™)

ERK2 Polyclonal Antibody for IHC (P)

ERK2 Polyclonal Antibody (Invitrogen™)

ERK2 Polyclonal Antibody for Western Blot

MAPK1 (ERK2) Recombinant Human Protein

MAPK1 (ERK2) is a serine⁄threonine kinase that acts as an important activator of p90 RSK, MSK, ELK1, and Stat3, and is involved in the MAPK pathway.

MAPK1 (ERK2) Recombinant Human Protein, Inactive

MAPK1 (ERK2) is a serine⁄threonine kinase that acts as an important activator of p90 RSK, MSK, ELK1, and Stat3, and is involved in the MAPK pathway.

CellSensor™ AP-1-bla ME-180 Cell Line

The CellSensor® AP-1-bla ME-180 Cell Line contains a beta-lactamase reporter gene under control of the AP-1 response element stably integrated into ME-180 cells. The cell line was created through FACS sorting of cells responsive to stimulation of the AP-1 pathway with Epidermal Growth Factor (EGF). This cell line was validated for DMSO tolerance, stimulant incubation time, substrate loading conditions, Z' and EC50 concentration of Epidermal Growth Factor. The AP-1-bla ME-180 Cell Line responds to agonist treatment as expected from the literature and can be adapted for high-throughput screening for agonists or antagonists of the AP-1 pathway with compound libraries. Candidate drugs can also be tested for dose response against this cell line. Academic and non-profit customers, please inquire for special pricing.

AKT/ERK/p70 S6K Activation Multispecies InstantOne™ ELISA Kit (Invitrogen™)

AKT/ERK/p70 S6K Activation Multispecies InstantOne™ ELISA Kit for ELISA